Oxidized lipids—fats structurally altered by enzymes, oxygen or free radicals—are double-edged swords that can both quell and ignite systemic inflammation, according to a new comprehensive review aimed at sharpening the overall understanding of an intricate class of highly reactive molecules.
Dr. Marco Di Gioia and Dr. Ivan Zanoni, two medical investigators from the divisions of immunology and gastroenterology at Harvard Medical School, explored this complex molecular universe by focusing on a class of compounds called oxidized phospholipids—oxPLs.
In their article published in Science Immunology, they explored why sharp differences in oxPL activity can have favorable or unfavorable biological outcomes. OxPLs, the authors emphasized, exemplify how a compound can possess one of two distinct sides. They explained how these molecules can act either as benign agents or ones capable of substantial harm.
The unfavorable side of oxPLs is especially noteworthy, the authors added, because of the roles these molecules play in an array of disease processes.
Oxidized lipids form when cellular fats interact with oxygen, altering the lipids’ chemical structure and turning these compounds into molecules that can either trigger or modulate inflammation. While oxPLs arise spontaneously from routine cellular stress, the authors report that these molecules can quickly evolve into highly reactive, biologically active compounds. Chemically, they can be generated when, for example, a cell membrane undergoes oxidative stress.
From byproducts to potent bioactive molecules
“Spontaneously generated oxidized lipids, including nonenzymatically oxidized phospholipids, result from oxidative stress and accumulate during inflammation, affecting cellular metabolism, immune cell functions and cell fate,” write Di Gioia and Zanoni, whose deep dive into this complex molecular universe was undertaken to highlight the importance of these molecules in human health and disease.
“These distinct classes of oxidized lipids not only share overlapping inflammatory roles but also exhibit divergent effects depending on their molecular structures and cellular targets,” they added.
The research joins a growing body of analyses that have zeroed in on the impact of oxidized lipids in disorders marked by chronic inflammation. Lipids undergoing enzymatic or nonenzymatic oxidation play critical roles in regulating inflammation, Di Gioia and Zanoni explain, noting that polyunsaturated fatty acids, cholesterol and cholesterol intermediates can be enzymatically oxidized and serve as signaling molecules altering tissue homeostasis and immunity.
The two investigators further explained their “double-edged sword” analogy by highlighting recent studies that investigated the biological effects of spontaneous lipid oxidation.
“Although their transient production triggers protective responses, their accumulation sustains inflammation, contributing to tissue damage,” they wrote, noting that emerging studies are revealing that oxPLs play prominent roles in cell death programs, immune cell activation and stromal cell functions, which are critical processes favoring tumor growth.
Fueling disease and tumors
Historically, oxPLs were viewed merely as benign byproducts of oxidative stress. But, as the two scientists underscore, oxPLs are now regarded as potent, bioactive molecules that can bind to specific receptors on immune cells, triggering intracellular signaling pathways.
This, in turn, disrupts cellular homeostasis, promotes chronic inflammation and actively drives the progression of various physiological conditions, such as aging, and—of greater concern—certain life-threatening disease processes.
Highly reactive oxPLs—those from the unfavorable side of the sword—were the focus of most of the analysis in the report.
These rogue lipids underlie some of humanity’s most devastating conditions, according to the authors, who linked the accumulation of oxPLs to a long, disparate list of ailments, including various forms of cancer, metabolic disorders, infections, asthma, inflammatory bowel disease, neurodegenerative disorders and pain syndromes.
The investigators further highlighted the damaging role that these molecules have deep within tumors. Inside the harsh tumor microenvironment, oxPLs accumulate abundantly and actively shape how cancer cells behave, effectively suppressing neighboring T cells while allowing the malignancy to evade the immune system.
Unmasking individual lipid structures
Right now, the full scope of these molecules remains unknown. The authors assert that current technology limits how thoroughly scientists can analyze various tissues, and they are calling for advancements in analytical and scientific techniques—such as high-resolution lipidomics and chiral chromatography—to fully unmask individual lipid structures.
Advances in techniques could help define the functions of distinct oxPLs within different tissue types. Indeed, if science can learn to precisely decode and control this molecular double-edged sword, it could unlock entirely new, targeted therapeutic strategies to halt chronic disease, combat aggressive cancers and slow the biological processes of aging, the authors say.
“Addressing these limitations will be critical for … the development of therapeutic strategies that selectively target pathogenic lipid oxidation or its downstream biological responses,” they concluded. https://medicalxpress.com/news/2026-10-rogue-lipids-routine-cellular-stress.html
Recent Comments